Search Results - "Kuwahara‐Ota, Saeko"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    EWSR1 overexpression is a pro-oncogenic event in multiple myeloma by Nishiyama, Daichi, Chinen, Yoshiaki, Isa, Reiko, Fujibayashi, Yuto, Kuwahara-Ota, Saeko, Yamaguchi, Junko, Takimoto-Shimomura, Tomoko, Matsumura-Kimoto, Yayoi, Tsukamoto, Taku, Shimura, Yuji, Kobayashi, Tsutomu, Horiike, Shigeo, Taniwaki, Masafumi, Handa, Hiroshi, Kuroda, Junya

    Published in International journal of hematology (01-03-2021)
    “…Multiple myeloma (MM) is cytogenetically, genetically and molecularly heterogenous even among subclones in one patient, therefore, it is essential to identify…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Tuberculosis Peritonitis During Treatment of Polycythemia Vera with Ruxolitinib by Sakiyama, Emiko, Chinen, Yoshiaki, Tsukamoto, Taku, Takimoto-Shimomura, Tomoko, Kuwahara-Ota, Saeko, Matsumura-Kimoto, Yayoi, Shimura, Yuji, Kobayashi, Tsutomu, Horiike, Shigeo, Kuroda, Junya

    Published in Infection and drug resistance (01-01-2020)
    “…Ruxolitinib is a selective JAK1/2 inhibitor that is widely used for the treatment of myeloproliferative neoplasms (MPNs), including myelofibrosis and…”
    Get full text
    Journal Article
  17. 17

    Phosphoinositide-dependent protein kinase 1 is a potential novel therapeutic target in mantle cell lymphoma by Maegawa, Saori, Chinen, Yoshiaki, Shimura, Yuji, Tanba, Kazuna, Takimoto, Tomoko, Mizuno, Yoshimi, Matsumura-Kimoto, Yayoi, Kuwahara-Ota, Saeko, Tsukamoto, Taku, Kobayashi, Tsutomu, Horiike, Shigeo, Taniwaki, Masafumi, Kuroda, Junya

    Published in Experimental hematology (01-03-2018)
    “…•3-Phosphoinositide-dependent protein kinase 1 (PDPK1) is found to be constitutively activated in various types of patient-derived B-cell non-Hodgkin lymphoma…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20